The tariff classification of Spironolactone Tablets in dosage form, from China
Reasoning
The tariff classification of Spironolactone Tablets in dosage form, from China
Cite this ruling
CBP Ruling N333556 (3004390050): The tariff classification of Spironolactone Tablets in dosage form, from China
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300439
The tariff classification of Lumigan™(bimatoprost ophthalmic solution) 0.03%, put up in plastic, ophthalmic dispenser-bottles
The tariff classification of Blephamide® (sulfacetamide sodium and prednisolone acetate ophthalmic ointment USP) 10% / 0.2%
The tariff classification of Blephamide® (sulfacetamide sodium - prednisolone acetate ophthalmic suspension) 10% / 0.2%
The tariff classification of Pramlintide Acetate (CAS-151126-32-8), imported in bulk form; and SYMLIN™ (pramlintide acetate), put up in 1.5 mL glass cartridges and 5 mL vials
The tariff classification of MYOTROPHIN® (mecasermin [recombinant DNA origin]) Injection, imported put up in single-dose vials; MYOTROPHIN® Injection, imported in bulk form; and Mecasermin (human insulin-like growth factor-1, human IGF-1) (CAS-68562-41-4), imported in bulk form, from Taiwan